Commentary: diagnostic utility of cytokeratin 17 immunostaining in morpheaform basal cell carcinoma and for facilitating the detection of tumor cells at the surgical margins
- PMID: 22861061
- DOI: 10.1111/j.1524-4725.2012.02446.x
Commentary: diagnostic utility of cytokeratin 17 immunostaining in morpheaform basal cell carcinoma and for facilitating the detection of tumor cells at the surgical margins
Comment on
-
Diagnostic utility of cytokeratin 17 immunostaining in morpheaform basal cell carcinoma and for facilitating the detection of tumor cells at the surgical margins.Dermatol Surg. 2012 Aug;38(8):1357-66. doi: 10.1111/j.1524-4725.2012.02417.x. Epub 2012 Jun 12. Dermatol Surg. 2012. PMID: 22691048 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical